PRINCIPAL FINANCIAL GROUP INC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1126328 DES MOINES, IA

Position in STOK

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,286,472

+$204,815 QoQ

Shares Held

69,880

+9.3% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#62

of 198 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. STOK ranks #50 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,286,472	69,880	+9.3%	Shares	Defined	2026-08-04
2026-03-31	$2,081,657	63,933	-9.0%	Shares	Defined	2026-05-04
2025-12-31	$2,230,750	70,282	+55.5%	Shares	Defined	2026-02-02
2025-09-30	$1,062,317	45,205	+332.5%	Shares	Defined	2025-11-04
2024-03-31	$141,088	10,451	-13.2%	Shares	Defined	2024-04-29
2023-12-31	$63,314	12,037	-0.8%	Shares	Defined	2024-02-07
2023-09-30	$47,795	12,131	+6.5%	Shares	Defined	2023-11-02
2023-06-30	$121,053	11,388	+36.1%	Shares	Defined	2023-08-07
2021-06-30	$281,565	8,365	+25.6%	Shares	Defined	2021-08-10
2020-09-30	$222,976	6,658	—	Shares	Defined	2020-11-06
No filing history on record for this holder in this stock.